The CDK-activating kinase Cdk7: taking yes for an answer.
about
CDK7-dependent transcriptional addiction in triple-negative breast cancer.A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.Radiosensitization of human glioma cells by tamoxifen is associated with the inhibition of PKC-ι activity in vitro.Improving the Understanding of Pathogenesis of Human Papillomavirus 16 via Mapping Protein-Protein Interaction Network.High MITF Expression is Associated with Super-enhancers and Suppressed by CDK7 Inhibition in Melanoma.ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.
P2860
The CDK-activating kinase Cdk7: taking yes for an answer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The CDK-activating kinase Cdk7: taking yes for an answer.
@en
The CDK-activating kinase Cdk7: taking yes for an answer.
@nl
type
label
The CDK-activating kinase Cdk7: taking yes for an answer.
@en
The CDK-activating kinase Cdk7: taking yes for an answer.
@nl
prefLabel
The CDK-activating kinase Cdk7: taking yes for an answer.
@en
The CDK-activating kinase Cdk7: taking yes for an answer.
@nl
P2860
P356
P1433
P1476
The CDK-activating kinase Cdk7: taking yes for an answer.
@en
P2093
Miriam Merzel Schachter
Robert P Fisher
P2860
P304
P356
10.4161/CC.26355
P577
2013-09-13T00:00:00Z